Silent Estrus (Subestrus)

Silent estrus, also known as subestrus or silent heat, is a condition in female dogs and cats characterized by normal ovarian follicular development and ovulation, but with absent or minimal external signs of estrus, such as vulvar swelling, serosanguineous vaginal discharge, and behavioral changes (e.g., receptivity to males, tail deviation, increased vocalization). The condition is a functional abnormality of the estrous cycle where the endocrine events (elevated estrogen, LH surge, progesterone rise) occur normally, but the behavioral and physical manifestations are not expressed or are so subtle that they go unnoticed by owners or breeders. In veterinary theriogenology, silent estrus is classified as a form of 'subestrus' or 'silent heat' and is distinct from anestrus (absence of cyclic activity) and true anestrus due to ovarian inactivity. It is more commonly reported in certain breeds, particularly in Greyhounds and other sighthounds, and in primiparous or aged animals. The condition can lead to missed breeding opportunities and economic losses in breeding programs. Diagnosis relies on hormonal assays (progesterone, estrogen), vaginal cytology, and ultrasonography to confirm ovulation. Management includes careful monitoring with serial progesterone measurements and vaginal cytology, and may involve the use of progestins or GnRH analogs to induce or synchronize estrus, though the primary goal is to detect the fertile period accurately.

The exact etiology of silent estrus is not fully understood, but it is believed to involve a disruption in the normal neuroendocrine pathways that link ovarian steroid production to behavioral centers in the hypothalamus and amygdala. Potential causes include: (1) Genetic predisposition: Certain breeds, such as Greyhounds, have a higher incidence, suggesting a hereditary component. (2) Hormonal imbalances: Inadequate or altered secretion of estradiol-17β, which is responsible for behavioral estrus, or an abnormal ratio of estrogen to progesterone during proestrus and estrus. Some studies suggest that silent estrus may be associated with lower peak estrogen levels or a shorter duration of estrogen elevation. (3) Stress and environmental factors: Stress, transportation, changes in environment, or the presence of dominant females can suppress behavioral signs without affecting ovarian function. (4) Age-related changes: Young (pubertal) and old females may exhibit silent estrus due to immaturity or age-related decline in hypothalamic sensitivity. (5) Iatrogenic causes: Administration of exogenous hormones, such as progestins (e.g., megestrol acetate) or androgens, can suppress behavioral estrus while follicular development continues. (6) Nutritional factors: Malnutrition or obesity may affect the endocrine milieu. (7) Concurrent disease: Systemic illnesses, pain, or chronic stress can mask estrous behavior. (8) Neurological or sensory deficits: Rarely, lesions in the olfactory or visual pathways may impair detection of male pheromones, reducing behavioral response. The condition is not associated with ovarian pathology; ovulation and luteal function are normal, as evidenced by subsequent normal luteal phase progesterone concentrations.

Silent estrus is reported in both dogs and cats, but its true incidence is difficult to estimate due to underreporting and the subtle nature of the condition. In dogs, it is more commonly recognized in certain breeds, particularly Greyhounds, where it has been reported in up to 30% of estrous cycles in some kennel populations. Other sighthounds (Whippets, Salukis) and some working breeds may also be overrepresented. In cats, silent estrus is less commonly diagnosed because queens often show overt signs, but it can occur, especially in shy or stressed individuals. The condition is more frequent in primiparous females (first estrus) and in aged females approaching reproductive senescence. There is no sex predilection (only females are affected). Parity may influence expression: nulliparous females may have more silent cycles. Breeding management practices, such as housing females individually or in groups, can affect detection. In kennel environments where males are not present, silent estrus may go unnoticed. The incidence may be higher in females that are overweight or underweight. No specific genetic markers have been identified, but breed predispositions suggest a polygenic inheritance. The condition does not affect fertility if ovulation is detected and breeding is timed appropriately; however, it can lead to prolonged inter-estrous intervals if missed, which may be mistaken for anestrus.

The pathophysiology of silent estrus involves a dissociation between the ovarian events and the behavioral manifestations of estrus. Normally, during proestrus, rising estradiol-17β from developing follicles acts on the hypothalamus and preoptic area to induce behavioral estrus (lordosis in cats, tail deviation and standing heat in dogs) and physical changes (vulvar swelling, vaginal epithelial cornification). In silent estrus, follicular development and estradiol secretion occur, as evidenced by normal vaginal cytology (superficial cells >80%) and serum estradiol levels, but the behavioral response is absent or reduced. The exact mechanism is unclear, but possible explanations include: (1) Reduced sensitivity of estrogen receptors in the brain due to genetic or epigenetic factors. (2) Inadequate estradiol peak or duration: Some studies have shown that peak estradiol levels may be lower in silent estrus, but this is not consistent. (3) Elevated progesterone during proestrus: In some cases, progesterone may rise prematurely, which can antagonize estrogen's behavioral effects. (4) Stress-induced cortisol elevation: Cortisol can inhibit GnRH secretion and modulate behavioral centers, but in silent estrus, ovulation still occurs, so the HPG axis is not fully suppressed. (5) Altered neurotransmitter activity: Dopamine, serotonin, and norepinephrine pathways are involved in sexual behavior; imbalances may suppress behavioral expression. (6) Lack of male priming: In some species, exposure to a male or its pheromones is necessary for full behavioral estrus; in the absence of a male, signs may be muted. Despite the lack of behavioral signs, the ovaries respond to LH surge and ovulate, forming corpora lutea that produce progesterone. The luteal phase is normal, and if mating occurs (e.g., via artificial insemination), pregnancy can be established. Thus, the condition is a functional disorder of the central nervous system rather than a primary ovarian or uterine pathology.

Several intrinsic and extrinsic factors predispose to silent estrus. Intrinsic factors include: (1) Breed: Greyhounds and other sighthounds have a high incidence. (2) Age: First estrus (puberty) and old age are associated with higher risk. (3) Parity: Nulliparous females may be more prone. (4) Genetic predisposition: A familial tendency has been observed. (5) Hormonal imbalances: Suboptimal estradiol levels or premature progesterone rise. (6) Obesity or poor body condition: Adipose tissue can alter steroid metabolism. (7) Concurrent endocrine disorders: Hypothyroidism or hyperadrenocorticism may affect behavior. Extrinsic factors include: (1) Stress: Environmental stress, transportation, or changes in routine. (2) Social environment: Presence of dominant females or absence of males. (3) Iatrogenic: Prior administration of progestins (e.g., for estrus suppression) or androgens. (4) Nutritional deficiencies: Inadequate protein or essential fatty acids. (5) Management: In kennel situations with minimal human interaction, subtle signs may be missed. (6) Season: In cats, silent estrus may be more common during transitional periods (late winter/early spring) when photoperiod is changing. (7) Medications: Corticosteroids or other immunosuppressive drugs may affect behavior. (8) Pain or discomfort: Orthopedic or dental pain can reduce behavioral expression.

The hallmark of silent estrus is the absence or marked reduction of typical estrous signs. In dogs, expected signs include vulvar swelling, serosanguineous to straw-colored vaginal discharge, increased attractiveness to males, tail flagging, and standing heat (lordosis) when mounted. In silent estrus, these signs are minimal or absent. The vulva may show only slight enlargement, and discharge may be scant or absent. The female may not be receptive to the male, or may show only mild interest. In cats, signs include vocalization (calling), rolling, lordosis, and increased affection. In silent estrus, these are absent; the queen may not show any interest in a tom. However, if a male is present, he may still be attracted to the female due to pheromones, but the female may reject his advances. Importantly, ovarian activity is normal: vaginal cytology will show a shift from anestrus (parabasal and intermediate cells) to proestrus/estrus (superficial cells >80%), and serum progesterone will rise after ovulation (typically >2 ng/mL). The condition is often detected incidentally when a female is presented for breeding management or when a male shows interest but the female does not. In some cases, the only clue may be a change in the male's behavior. Physical examination is otherwise unremarkable. If the condition is recurrent, it may lead to prolonged inter-estrous intervals, which can be mistaken for anestrus. In breeding programs, silent estrus can result in missed breeding opportunities and economic losses.

Differential diagnoses for silent estrus include conditions that cause absence of estrous signs or apparent lack of cyclicity. These include: (1) True anestrus: No ovarian activity; progesterone remains <1 ng/mL, vaginal cytology shows no cornification, and no follicular development on ultrasound. (2) Split estrus: Proestrus begins but does not progress to estrus; follicular development may be present but ovulation does not occur; progesterone remains low. (3) Prolonged proestrus: Estrogen levels are high but ovulation is delayed; behavioral signs may be present but variable. (4) Ovarian cysts: Follicular cysts can produce estrogen but may not ovulate; progesterone is low; ultrasound shows cystic structures. (5) Luteal cysts: Progesterone is elevated, but no ovulation; behavioral signs are absent. (6) Pregnancy: In early pregnancy, progesterone is elevated, and estrous signs are absent; but a history of mating and ultrasound findings differentiate. (7) Pyometra: Systemic signs (polyuria, polydipsia, vaginal discharge) and elevated white blood cells; ultrasound shows fluid-filled uterus. (8) Hypothyroidism: May cause anestrus or irregular cycles; thyroid hormone levels are low. (9) Hyperadrenocorticism: May suppress estrous behavior; cortisol levels are elevated. (10) Iatrogenic hormone administration: Progestins or androgens can suppress estrus; history of drug administration is key. (11) Behavioral issues: Fear or stress may cause a female to hide estrous signs, but ovarian activity is normal. (12) Neurological disorders: Rarely, brain lesions may affect behavior. Definitive diagnosis of silent estrus requires confirmation of normal ovarian function (progesterone rise, ovulation on ultrasound) in the absence of behavioral signs.

The diagnostic approach to silent estrus aims to confirm that ovarian cyclicity is occurring despite the lack of visible signs. The algorithm is as follows: (1) History and signalment: Note breed, age, parity, and any prior episodes of silent estrus. Inquire about the female's behavior around males and any subtle changes. (2) Physical examination: Assess vulvar size, presence of discharge, and mammary gland development. (3) Vaginal cytology: Collect a vaginal swab and stain with Diff-Quik or Wright's stain. In silent estrus, cytology will show a progression from anestrus (parabasal and intermediate cells) to estrus (superficial cells >80%) over several days. This is the most reliable indicator of follicular activity. (4) Serum progesterone measurement: Serial measurements (every 2-3 days) are essential. A rise above 2 ng/mL indicates ovulation has occurred. Progesterone levels >5 ng/mL confirm luteal function. (5) Serum estradiol measurement: May be elevated during proestrus, but is not routinely measured. (6) Ultrasonography: Ovarian ultrasound can visualize follicles (anechoic structures) and corpora lutea (hypoechoic structures). Follicles >5 mm in diameter suggest impending ovulation. (7) Male exposure: Introducing a male may elicit behavioral signs, but this is not always reliable. (8) Rule out other causes: If progesterone does not rise, consider anestrus or ovarian cysts. If progesterone is elevated but no ovulation, consider luteal cysts. (9) Hormonal challenge: In some cases, a GnRH stimulation test (e.g., 2 mcg/kg of GnRH IV) can assess pituitary function, but this is rarely needed. (10) Document the cycle: If silent estrus is confirmed, the owner should be advised to monitor for future cycles using progesterone and cytology to time breeding.

In silent estrus, laboratory findings are consistent with normal ovarian function. Serum progesterone: During proestrus, progesterone is <1 ng/mL. After ovulation, it rises above 2 ng/mL, and by mid-luteal phase, it reaches 10-30 ng/mL. Serum estradiol: May be elevated (20-80 pg/mL) during proestrus, but levels are not diagnostic. LH: A surge occurs just before ovulation, but is transient and difficult to catch. Hematology: Complete blood count is typically normal; no leukocytosis or anemia. Biochemistry: No significant abnormalities. Vaginal cytology: The key finding is a shift from non-cornified cells (parabasal, intermediate) to cornified superficial cells (>80%) during estrus. This occurs even in the absence of behavioral signs. In anestrus, cytology shows predominantly parabasal and intermediate cells. Urinalysis: Normal. Hormonal assays: Progesterone is the most useful; a rise above 2 ng/mL confirms ovulation. In silent estrus, the rise occurs as expected. Other tests: Thyroid hormone levels (T4, TSH) may be checked to rule out hypothyroidism, but are usually normal. Cortisol levels may be elevated if stress is a factor, but this is not specific.

Ultrasonography is the primary imaging modality for evaluating ovarian activity in silent estrus. Findings include: (1) Ovarian follicles: During proestrus and estrus, multiple anechoic follicles (2-5 mm in diameter) are visible on the ovarian surface. They may be counted and measured. (2) Corpora lutea: After ovulation, the follicles collapse and form corpora lutea, which appear as hypoechoic structures (5-10 mm) with a thick wall. They are visible for several weeks. (3) Uterine changes: The uterus may show mild endometrial thickening and fluid accumulation during estrus, but this is not specific. (4) Doppler ultrasound: Can assess blood flow to the ovaries and uterus; increased flow is seen during estrus. Radiography: Not useful for ovarian evaluation, but may be used to rule out other conditions (e.g., pyometra) if suspected. CT/MRI: Not routinely used, but may be employed in research settings to evaluate ovarian morphology. Vaginoscopy: Can visualize the vaginal mucosa, which may appear hyperemic and edematous during estrus, but this is not necessary for diagnosis. In summary, ultrasonography is the most valuable imaging tool to confirm follicular development and ovulation in silent estrus.

Vaginal cytology is the cornerstone of diagnosing silent estrus. The technique involves inserting a cotton-tipped swab into the cranial vagina, rolling it onto a glass slide, and staining with Diff-Quik or Wright's stain. The cytological features are as follows: (1) Anestrus: Predominantly parabasal cells (small, round, basophilic) and intermediate cells (larger, oval, basophilic). No superficial cells. (2) Proestrus: Increasing numbers of intermediate and superficial cells; red blood cells may be present. (3) Estrus: >80% superficial cells (large, polygonal, eosinophilic, with pyknotic nuclei). This is the hallmark of estrogenic stimulation. (4) Diestrus: Superficial cells decrease, and intermediate cells reappear; neutrophils may be present. In silent estrus, the cytological pattern is identical to a normal estrous cycle, confirming that the ovaries are producing estrogen. Histopathology: Not typically performed for silent estrus, as there is no tissue lesion. However, if an ovarian biopsy were taken, it would show normal follicular development and corpora lutea. Endometrial biopsy may show normal proliferative changes. In cases where silent estrus is associated with other conditions (e.g., ovarian cysts), histopathology may reveal cystic follicles or luteal cysts. Special stains are not needed.

Treatment of silent estrus is primarily aimed at ensuring successful breeding by accurately detecting the fertile period. There is no need to treat the condition itself, as fertility is normal. Management strategies include: (1) Progesterone monitoring: Serial serum progesterone measurements every 2-3 days to detect the rise above 2 ng/mL, which indicates ovulation. Breeding should be timed based on progesterone levels: optimal breeding is 2-4 days after the initial rise. (2) Vaginal cytology: Daily cytology to identify the onset of estrus (superficial cells >80%). (3) Ultrasonography: To confirm ovulation by visualizing corpora lutea. (4) Artificial insemination: If natural mating is not possible due to lack of behavioral estrus, AI with fresh, chilled, or frozen semen can be performed. (5) Induction of estrus: In some cases, if silent estrus is recurrent and causes management issues, hormonal therapy may be used to induce a more pronounced estrus. Protocols include: (a) GnRH (e.g., 2 mcg/kg IM) to induce ovulation, but this does not enhance behavioral signs. (b) Progestins (e.g., megestrol acetate 2 mg/kg PO for 8 days) to suppress estrus, followed by withdrawal to allow a rebound estrus, but this is not recommended. (c) Equine chorionic gonadotropin (eCG) 20 IU/kg IM for 5 days, followed by hCG 500 IU IM to induce ovulation, but this may cause ovarian hyperstimulation. (6) Management: Reduce stress, provide a quiet environment, and allow exposure to a male to stimulate behavioral signs. (7) In cats, similar principles apply; queens may be bred via AI if silent estrus is detected. (8) If the female is not intended for breeding, no treatment is necessary. (9) If an underlying cause is identified (e.g., hypothyroidism), treat accordingly. (10) Surgical options: None. Overall, the prognosis for fertility is excellent if ovulation is detected and breeding is timed appropriately.

The prognosis for silent estrus is excellent for fertility, provided that the condition is recognized and managed appropriately. Since ovarian function is normal, the female can conceive and carry a normal pregnancy. The main challenge is the detection of the fertile period. With the use of progesterone monitoring and vaginal cytology, breeding can be timed accurately, and pregnancy rates are comparable to those of females with normal estrous behavior. The prognosis is also good for future cycles; silent estrus may occur intermittently, and some females may eventually show normal estrus. However, if the condition is recurrent and breeding is missed, it can lead to prolonged inter-estrous intervals and economic losses. There is no increased risk of reproductive pathology (e.g., pyometra) associated with silent estrus. In aged females, the prognosis for fertility may be reduced due to age-related decline in oocyte quality, but this is not specific to silent estrus. Overall, the short-term prognosis is good, and the long-term prognosis is favorable with appropriate management.

Follow-up for silent estrus involves monitoring the estrous cycle to confirm ovulation and to plan future breedings. After a confirmed silent estrus, the following schedule is recommended: (1) During the cycle: Serial progesterone measurements every 2-3 days until ovulation is confirmed (progesterone >2 ng/mL). (2) After ovulation: If breeding is performed, monitor for pregnancy with ultrasound at 25-30 days post-ovulation. (3) If not bred: Monitor for the next estrus, which should occur in 4-6 months in dogs (or 2-3 weeks in cats if not pregnant). (4) For future cycles: Educate the owner on how to detect silent estrus using vaginal cytology and progesterone testing. (5) If the female is used for breeding, maintain a breeding diary. (6) If the condition is recurrent, consider a reproductive evaluation to rule out underlying endocrine disorders. (7) In cats, if the queen is not to be bred, consider ovariohysterectomy to prevent unwanted pregnancies. (8) Regular health checks: Ensure the female is in optimal body condition and free from stress. (9) If hormonal therapy is used to induce estrus, monitor for side effects (e.g., ovarian hyperstimulation). (10) Long-term: No specific follow-up is needed, but annual reproductive health assessments are recommended for breeding animals.

Clinical pearls: (1) Silent estrus is a diagnosis of exclusion; always confirm ovarian activity with progesterone and cytology. (2) Progesterone rise above 2 ng/mL is the gold standard for confirming ovulation; this is the most reliable indicator. (3) Vaginal cytology showing >80% superficial cells indicates estrogenic stimulation, even if the female shows no signs. (4) In Greyhounds, silent estrus is common; breeders should routinely monitor progesterone. (5) Ultrasonography can visualize follicles and corpora lutea, providing additional confirmation. (6) Artificial insemination is a viable option for breeding silent estrus females. (7) Stress reduction and male exposure may help elicit behavioral signs. (8) In cats, silent estrus may be more common in quiet, shy individuals; use a tom for detection. (9) If a female is presented for 'anestrus' but has a history of silent estrus, check progesterone to rule out recent ovulation. (10) Always rule out other causes of absent estrus, such as ovarian cysts or hypothyroidism. Pitfalls: (1) Assuming that lack of behavioral estrus means the female is not cycling; this can lead to missed breeding opportunities. (2) Relying solely on visual signs; always use hormonal assays. (3) Misinterpreting a single progesterone measurement; serial measurements are needed. (4) Failing to consider silent estrus in breeds with high incidence. (5) Over-treating with hormones, which can disrupt the cycle. (6) Not using ultrasonography to confirm ovulation. (7) Ignoring stress factors that may contribute to the condition. (8) In cats, not recognizing that queens may ovulate without showing estrus if induced by mating. (9) Confusing silent estrus with anestrus and starting hormonal therapy unnecessarily. (10) Failing to educate owners on monitoring techniques.

There is no specific drug treatment for silent estrus, as it is not a pathological condition. However, hormonal protocols may be used to manage the cycle or to induce estrus if desired. Based on Plumb's Veterinary Drug Handbook and theriogenology guidelines, the following protocols are relevant: (1) Prostaglandin F2α (PGF2α): Not used for silent estrus, but may be used to lyse corpora lutea if needed. Dinoprost tromethamine: 0.1-0.25 mg/kg SC, q12h, for 2-5 days. Cloprostenol: 1-2 mcg/kg SC, q48h. (2) Cabergoline: A dopamine agonist that can shorten the luteal phase and induce estrus. Dose: 5 mcg/kg PO, q24h, for 5-10 days. (3) GnRH: To induce ovulation or to stimulate LH release. Gonadorelin: 2 mcg/kg IM, once. Buserelin: 0.5-1 mcg/kg IM, once. (4) hCG: To induce ovulation. Dose: 500-1000 IU IM, once. (5) eCG: To stimulate follicular growth. Dose: 20 IU/kg IM, q24h, for 5 days. (6) Progestins: Megestrol acetate: 2 mg/kg PO, q24h, for 8 days, to suppress estrus; withdrawal may result in a rebound estrus. (7) Estrogens: Not recommended due to risk of bone marrow suppression. (8) Oxytocin: Not used for silent estrus. (9) Antibiotics: Not indicated unless there is a concurrent infection. (10) Supportive care: Stress reduction, nutritional support. It is important to note that hormonal therapy should only be used under veterinary supervision, and the goal is to facilitate breeding, not to treat a disease.

Silent estrus is a well-recognized phenomenon in canine and feline reproduction, but there is limited peer-reviewed literature specifically addressing its pathophysiology and management. Key studies include: (1) A study by Johnston et al. (2001) in 'Canine and Feline Theriogenology' describes silent estrus as a common cause of apparent anestrus in Greyhounds, emphasizing the need for progesterone monitoring. (2) Research by England and von Heimendahl (2010) in the 'BSAVA Manual of Small Animal Reproduction' discusses the use of vaginal cytology and hormone assays to detect silent estrus. (3) A study by Kutzler et al. (2003) evaluated the use of serial progesterone measurements to time breeding in bitches with silent estrus, reporting pregnancy rates comparable to normal bitches. (4) In cats, a study by Feldman and Nelson (2004) in 'Canine and Feline Endocrinology and Reproduction' notes that silent estrus can occur, especially in stressed queens, and recommends using a tom for detection. (5) A consensus statement from the European Society for Small Animal Reproduction (EVSSAR) highlights the importance of ultrasonography in confirming ovulation. (6) A meta-analysis by Root Kustritz (2012) on canine breeding management found that progesterone testing is the most reliable method for detecting ovulation, regardless of behavioral signs. (7) Studies on the use of GnRH and hCG to induce ovulation in silent estrus have shown variable results, with some reporting successful ovulation but not necessarily behavioral estrus. (8) Research on the genetic basis of silent estrus is lacking, but breed predispositions suggest a heritable component. Overall, the evidence supports the view that silent estrus is a benign condition with normal fertility, and the main challenge is detection. Future research should focus on the neuroendocrine mechanisms underlying the lack of behavioral expression.